-
14081por Lin, Chia-Chen, Su, Shih-Huan, Jeng, Wen-Juei, Huang, Chien-Hao, Teng, Wei, Chen, Wei-Ting, Chen, Yi-Cheng, Lin, Chun-Yen, Sheen, I-Shyan“…BACKGROUND: Chemokines/cytokines play important roles in the pathogenesis of chronic hepatitis C (CHC). However, their clinical characteristics and implications in treatment responses to pegylated interferon plus ribavirin treatment (PegIFN/RBV) have not been fully illustrated yet. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14082por von Delft, Annette, Donnison, Timothy A., Lourenço, José, Hutchings, Claire, Mullarkey, Caitlin E., Brown, Anthony, Pybus, Oliver G., Klenerman, Paul, Chinnakannan, Senthil, Barnes, Eleanor“…BACKGROUND: Hepatitis C virus (HCV) genomic variability is a major challenge to the generation of a prophylactic vaccine. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14083por Nguyen-Dinh, Song-Huy, Do, Albert, Pham, Trang Ngoc Doan, Dao, Doan Y, Nguy, Trinh Nhu, Chen, Moon S“…We collected information on patient age, gender, geographic distribution, and disease characteristics including disease stage, tumor biomarker levels [serum alpha-fetoprotein (AFP), AFP-L3 isoform percentage, and prothrombin induced by induced by vitamin K absence-II], and serological testing for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. RESULTS: Data from 24091 HCC patients were extracted, with sample demographics comprising mostly male (81.8%) and older age (however with 8.5% younger than 40 years old). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14084por Grebely, Jason, Feld, Jordan J, Wyles, David, Sulkowski, Mark, Ni, Liyun, Llewellyn, Joe, Mir, Heshaam M, Sajed, Nika, Stamm, Luisa M, Hyland, Robert H, McNally, John, Brainard, Diana M, Jacobson, Ira, Zeuzem, Stefan, Bourlière, Marc, Foster, Graham, Afdhal, Nezam, Dore, Gregory J“…BACKGROUND: Hepatitis C virus (HCV) direct-acting antiviral therapy is effective among people receiving opioid substitution therapy (OST), but studies are limited by small numbers of nongenotype 1 (GT1) patients. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14085por Trifan, Anca, Stanciu, Carol, Gheorghe, Liana, Iacob, Speranta, Curescu, Manuela, Cijevschi Prelipcean, Cristina, Stefanescu, Gabriela, Girleanu, Irina, Chiriac, Stefan, Mihai, Catalina, Brisc, Ciprian, Goldis, Adrian, Sporea, Ioan, Miftode, Egidia, Bataga, Simona, Rogoveanu, Ion, Preda, Carmen, Caruntu, Florin Alexandru, Singeap, Ana-Maria“…Advanced age has been a major limitation of interferon-based treatment for chronic hepatitis C virus (HCV) infection because of its poor response and tolerability. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14086por Chromy, David, Schwabl, Philipp, Bucsics, Theresa, Scheiner, Bernhard, Strassl, Robert, Mayer, Florian, Aichelburg, Maximilian C., Grabmeier-Pfistershammer, Katharina, Trauner, Michael, Peck-Radosavljevic, Markus, Reiberger, Thomas, Mandorfer, Mattias“…BACKGROUND AND AIM: Hepatitis C virus (HCV) therapy should be considered without delay in all patients with significant (SIGFIB) or advanced liver fibrosis (ADVFIB). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14087por Stengel, Camille May, Mane, Famara, Guise, Andrew, Pouye, Magath, Sigrist, Monika, Rhodes, Tim“…This is in response to growing injecting drug use across the West Africa region and linked emerging epidemics of HIV and hepatitis C. We undertook formative qualitative research to explore the feasibility and potential of peer outreach in this context and in particular how outreach could be linked to fostering community-level processes of change. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14088por Thongprayoon, Charat, Kaewput, Wisit, Sharma, Konika, Wijarnpreecha, Karn, Leeaphorn, Napat, Ungprasert, Patompong, Sakhuja, Ankit, Cabeza Rivera, Franco H, Cheungpasitporn, Wisit“…These associations existed in overall analysis as well as in limited cohort of hepatitis C virus-negative patients. We found no publication bias as assessed by the funnel plots and Egger’s regression asymmetry test with P = 0.18 and 0.13 for the risks of mortality and allograft failure after kidney transplantation in HBsAg-positive recipients, respectively. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14089“…INTRODUCTION: Hepatitis B virus infection is a public health concern in Cameroon and worldwide. With hepatitis C virus, it is the first cause of liver cancer in Cameroon. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14090por Chiu, King-Wah, Nakano, Toshiaki, Chen, Kuang-Den, Hu, Tsung-Hui, Lin, Chih-Che, Hsu, Li-Wen, Chen, Chao-Long, Goto, Shigeru“…The aim of this study is to elucidate the biogenetic modification of donor and recipient interleukin-28B (IL-28B) genotypes in liver graft biopsies after living donor liver transplantation (LDLT) for chronic hepatitis C virus- (HCV-) related, end-stage liver disease. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14091por Binka, Mawuena, Butt, Zahid A, Wong, Stanley, Chong, Mei, Buxton, Jane A, Chapinal, Nuria, Yu, Amanda, Alvarez, Maria, Darvishian, Maryam, Wong, Jason, McGowan, Gina, Torban, Mikhail, Gilbert, Mark, Tyndall, Mark, Krajden, Mel, Janjua, Naveed Z“…METHODS: We used data from the BC Hepatitis Testers Cohort (BC-HTC), which includes all individuals tested for hepatitis C virus (HCV) or human immunodeficiency virus (HIV) or those diagnosed with HBV or active tuberculosis in BC since 1990. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14092por Wei, Lai, Xie, Qing, Hou, Jin Lin, Tang, Hong, Ning, Qin, Cheng, Jun, Nan, Yuemin, Zhang, Lunli, Li, Jun, Jiang, Jianning, McNabb, Brian, Zhang, Fangqiu, Camus, Gregory, Mo, Hongmei, Osinusi, Anu, Brainard, Diana M., Gong, Guozhong, Mou, Zhuangbo, Wu, Shanming, Wang, Guiqiang, Hu, Peng, Gao, Yanhang, Jia, Jidong, Duan, Zhongping“…BACKGROUND: Chronic hepatitis C virus (HCV) infection is a significant medical burden in China, affecting more than 10 million persons. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14093“…Although DAAs increased virologic cure rates well over 90% in all hepatitis C virus (HCV) genotypes, HCV infection still cannot be cured in a small but significant minority of patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14094por Provine, Nicholas M., Binder, Benedikt, FitzPatrick, Michael E. B., Schuch, Anita, Garner, Lucy C., Williamson, Kate D., van Wilgenburg, Bonnie, Thimme, Robert, Klenerman, Paul, Hofmann, Maike“…Finally, we investigated the frequency and functionality of γδT cells in the context of chronic hepatitis C virus infection, as MAIT cells are reduced in frequency in this disease. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14095por Reddy, K. Rajender, Pol, Stanislas, Thuluvath, Paul J., Kumada, Hiromitsu, Toyota, Joji, Chayama, Kazuaki, Levin, James, Lawitz, Eric J., Gadano, Adrian, Ghesquiere, Wayne, Gerken, Guido, Brunetto, Maurizia R., Peng, Cheng‐Yuan, Silva, Marcelo, Strasser, Simone I., Heo, Jeong, McPhee, Fiona, Liu, Zhaohui, Yang, Rong, Linaberry, Misti, Noviello, Stephanie“…BACKGROUND & AIMS: Daclatasvir has achieved high sustained virologic response (SVR) rates in diverse hepatitis C virus (HCV) populations. This study evaluated the long‐term efficacy and safety of daclatasvir‐based regimens administered during clinical studies. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14096por Wymant, Chris, Blanquart, François, Golubchik, Tanya, Gall, Astrid, Bakker, Margreet, Bezemer, Daniela, Croucher, Nicholas J, Hall, Matthew, Hillebregt, Mariska, Ong, Swee Hoe, Ratmann, Oliver, Albert, Jan, Bannert, Norbert, Fellay, Jacques, Fransen, Katrien, Gourlay, Annabelle, Grabowski, M Kate, Gunsenheimer-Bartmeyer, Barbara, Günthard, Huldrych F, Kivelä, Pia, Kouyos, Roger, Laeyendecker, Oliver, Liitsola, Kirsi, Meyer, Laurence, Porter, Kholoud, Ristola, Matti, van Sighem, Ard, Berkhout, Ben, Cornelissen, Marion, Kellam, Paul, Reiss, Peter, Fraser, Christophe“…We also successfully applied shiver to whole-genome samples of Hepatitis C Virus and Respiratory Syncytial Virus. shiver is publicly available from https://github.com/ChrisHIV/shiver.…”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14097por Wu, Honghan, Toti, Giulia, Morley, Katherine I, Ibrahim, Zina M, Folarin, Amos, Jackson, Richard, Kartoglu, Ismail, Agrawal, Asha, Stringer, Clive, Gale, Darren, Gorrell, Genevieve, Roberts, Angus, Broadbent, Matthew, Stewart, Robert, Dobson, Richard JB“…In 2 Clinical Record Interactive Search–based studies, SemEHR achieved 93% (hepatitis C) and 99% (HIV) F-measure results in identifying true positive patients. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14098por Su, Shu, Zhang, Lei, Cheng, Feng, Li, Shunxiang, Li, Shifu, Jing, Jun, Fairley, Christopher Kincaid, Chen, Liang, Zhao, Jinxian, Mao, Limin“…SETTING: A detoxification centre in Southwest China, a part of the Chinese national sentential surveillance network for hepatitis C virus (HCV), HIV and syphilis infections, was recruited. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14099por Samawi, Haider H., Sim, Hao‐Wen, Chan, Kelvin K., Alghamdi, Mohammad A., Lee‐Ying, Richard M., Knox, Jennifer J., Gill, Parneet, Romagnino, Adriana, Batuyong, Eugene, Ko, Yoo‐Joung, Davies, Janine M., Lim, Howard J., Cheung, Winson Y., Tam, Vincent C.“…On multivariate analysis, hepatitis C, alcoholism, and prior hepatic resection were independently prognostic of better survival (P < 0.01). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14100por Bhatia, Mohit, Gupta, Ekta, Choudhary, Manish C., Jindal, Ankur, Sarin, Shiv Kumar“…CONTEXT: Occult hepatitis B infection (OBI) may contribute to liver damage and variable therapeutic response in patients with chronic hepatitis C (CHC) infection. AIMS: To study the prevalence of OBI and to evaluate its impact and/or that of anti-HBc total seropositivity on clinical outcomes and response to directly acting antiviral (DAA) therapy in CHC-infected patients. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto